Description
Rinvoq is a prescription medication containing upadacitinib, a selective and reversible JAK inhibitor used to treat moderate to severe active rheumatoid arthritis, psoriatic arthritis, and atopic dermatitis. As the original manufacturer, AbbVie ensures the availability of this specialty drug in the Philippines for patients requiring advanced immunological therapy.
Best for
Rheumatoid arthritis treatment, Psoriatic arthritis patients, Moderate to severe atopic dermatitis and Specialized immunological care